Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: a review. Eur J Intern Med. 2016;31:3–10.


Google Scholar 

Poh AWY, Teo SP. Utility of frailty screening tools in older surgical patients. Ann Geriatr Med Res. 2020;24(2):75–82.


Google Scholar 

Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Biol Sci Med Sci. 2001;56(3):M146–156.


Google Scholar 

Goh J, Wong E, Soh J, Maier AB, Kennedy BK. Targeting the molecular & cellular pillars of human aging with exercise. FEBS J. 2023;290(3):649–68.


Google Scholar 

Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15(9):505–22.


Google Scholar 

Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, Ferrucci L, Gilroy DW, Fasano A, Miller GW, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822–32.


Google Scholar 

Howlett SE, Rutenberg AD, Rockwood K. The degree of frailty as a translational measure of health in aging. Nat Aging. 2021;1(8):651–65.


Google Scholar 

Kang S, Narazaki M, Metwally H, Kishimoto T. Historical overview of the interleukin-6 family cytokine. J Exp Med. 2020. https://doi.org/10.1084/jem.20190347.


Google Scholar 

McKechnie DGJ, Papacosta AO, Lennon LT, Ramsay SE, Whincup PH, Wannamethee SG. Associations between inflammation, cardiovascular biomarkers and incident frailty: the British regional heart study. Age Ageing. 2021;50(6):1979–87.


Google Scholar 

Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol. 2016;12(1):49–62.


Google Scholar 

Decourt B, Lahiri DK, Sabbagh MN. Targeting tumor necrosis factor alpha for Alzheimer’s disease. Curr Alzheimer Res. 2017;14(4):412–25.


Google Scholar 

Buigues C, Navarro-Martinez R, Sanchez-Martinez V, Serrano-Carrascosa M, Rubio-Briones J, Cauli O. Interleukin-6 and lymphocyte count associated and predicted the progression of frailty syndrome in prostate cancer patients undergoing antiandrogen therapy. Cancers (Basel). 2020. https://doi.org/10.3390/cancers12071716.


Google Scholar 

Furtado GE, Uba Chupel M, Minuzzi L, Patricio M, Loureiro M, Bandelow S, Hogervorst E, Ferreira JP, Teixeira AM. Exploring the potential of salivary and blood immune biomarkers to elucidate physical frailty in institutionalized older women. Exp Gerontol. 2020;129:110759.


Google Scholar 

Grogan JL, Locksley RM. T helper cell differentiation: on again, off again. Curr Opin Immunol. 2002;14(3):366–72.


Google Scholar 

Fuku N, Mori S, Murakami H, Gando Y, Zhou H, Ito H, et al. Association of 29C > T polymorphism in the transforming growth factor-beta1 gene with lean body mass in community-dwelling Japanese population. Geriatr Gerontol Int. 2012;12(2):292–7.


Google Scholar 

Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y. Association of a T29–>C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation. 2000;101(24):2783–7.


Google Scholar 

Yamada Y. Association of polymorphisms of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis. Pharmacogenetics. 2001;11(9):765–71.


Google Scholar 

Juarez-Cedillo T, Martinez-Rodriguez N, Juarez-Cedillo E, Ramirez A, Suerna-Hernandez A. Intergenic interactions of ESR1, GSTO1 and AGER and risk of dementia in community-dwelling elderly (SADEM study). Genes. 2024. https://doi.org/10.3390/genes15111395.


Google Scholar 

Sanchez-Garcia S, Sanchez-Arenas R, Garcia-Pena C, Rosas-Carrasco O, Avila-Funes JA, Ruiz-Arregui L, Juarez-Cedillo T. Frailty among community-dwelling elderly Mexican people: prevalence and association with sociodemographic characteristics, health state and the use of health services. Geriatr Gerontol Int. 2014;14(2):395–402.


Google Scholar 

Douketis JD, Paradis G, Keller H, Martineau C. Canadian guidelines for body weight classification in adults: application in clinical practice to screen for overweight and obesity and to assess disease risk. CMAJ. 2005;172(8):995–8.


Google Scholar 

Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075–9. discussion 1081–1090.


Google Scholar 

Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of adl: A standardized measure of biological and psychosocial function. JAMA. 1963;185:914–9.


Google Scholar 

Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–86.


Google Scholar 

Fried LPaW J. (1998) Frailty and failure to thrive. In: Hazzard, W.R., Blass, J.P., Ettinger, W.H.Jr., Halter, J.B. and Ouslander, J. Eds., Principles of Geriatric Medicine and Gerontology, 4th Edition, McGraw Hill, New York, pp. 1387–1402.

Mathaiyan J, Chandrasekaran A, Davis S. Ethics of genomic research. Perspect Clin Res. 2013;4(1):100–4.


Google Scholar 

Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the Preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991;19(19):5444.


Google Scholar 

Cohen CI, Benyaminov R, Rahman M, Ngu D, Reinhardt M. Frailty: a multidimensional biopsychosocial syndrome. Med Clin North Am. 2023;107(1):183–97.


Google Scholar 

Cesari M, Calvani R, Marzetti E. Frailty in older persons. Clin Geriatr Med. 2017;33(3):293–303.


Google Scholar 

Nakazato Y, Sugiyama T, Ohno R, Shimoyama H, Leung DL, Cohen AA, et al. Estimation of homeostatic dysregulation and frailty using biomarker variability: a principal component analysis of hemodialysis patients. Sci Rep. 2020;10(1):10314.


Google Scholar 

Juarez-Cedillo T, Vargas-Alarcon G, Martinez-Rodriguez N, Juarez-Cedillo E, Fragoso JM, Escobedo-de-la-Pena J. Interleukin 10 gene polymorphisms and frailty syndrome in elderly Mexican people: (Sadem study). Mol Genet Genomic Med. 2019;7(9):e918.


Google Scholar 

Wang C, Wang J, Wan R, Kurihara H, Wang M. The causal association between Circulating cytokines with the risk of frailty and sarcopenia under the perspective of geroscience. Front Endocrinol (Lausanne). 2024;15:1293146.


Google Scholar 

Picca A, Coelho-Junior HJ, Calvani R, Marzetti E, Vetrano DL. Biomarkers shared by frailty and sarcopenia in older adults: A systematic review and meta-analysis. Ageing Res Rev. 2022;73:101530.


Google Scholar 

Xu Y, Wang M, Chen D, Jiang X, Xiong Z. Inflammatory biomarkers in older adults with frailty: a systematic review and meta-analysis of cross-sectional studies. Aging Clin Exp Res. 2022;34(5):971–87.


Google Scholar 

Sanchez-Castellano C, Martin-Aragon S, Bermejo-Bescos P, Vaquero-Pinto N, Miret-Corchado C, de Merello A, Cruz-Jentoft AJ. Biomarkers of sarcopenia in very old patients with hip fracture. J Cachexia Sarcopenia Muscle. 2020;11(2):478–86.


Google Scholar 

Porter GA, O’Connor JC. Brain-derived neurotrophic factor and inflammation in depression: pathogenic partners in crime? World J Psychiatry. 2022;12(1):77–97.


Google Scholar 

Pothier K, Gana W, Bailly N, Fougere B. Associations between frailty and Inflammation, Physical, and Psycho-Social health in older adults: A systematic review. Front Psychol. 2022;13:805501.


Google Scholar 

Xu M, Tchkonia T, Ding H, Ogrodnik M, Lubbers ER, Pirtskhalava T, White TA, Johnson KO, Stout MB, Mezera V, et al. JAK Inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proc Natl Acad Sci U S A. 2015;112(46):E6301–6310.


Google Scholar 

Pastorino R, Loreti C, Giovannini S, Ricciardi W, Padua L, Boccia S. Challenges of prevention for a sustainable personalized medicine. J Pers Med. 2021. https://doi.org/10.3390/jpm11040311.


Google Scholar